---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-005616"
form_type: "8-K"
ticker: "ACTU"
cik: "0001652935"
company_name: "ACTUATE THERAPEUTICS, INC."
filed_at: "2026-07-17T20:30:34+00:00"
generated_at: "2026-07-17T20:31:05.191043+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Actuate Therapeutics receives Nasdaq delisting notice for MVLS below $50M

## Summary
- Received Nasdaq notice on July 15, 2026 that Market Value of Listed Securities fell below $50M minimum.
- Has 180 calendar days, until January 11, 2027, to regain compliance by closing at $50M+ for 10 consecutive days.
- If not compliant by deadline, Nasdaq will issue delisting notice; company may appeal or apply to transfer to Nasdaq Capital Market.
- Common stock continues trading under symbol ACTU with no immediate effect on listing.

## SEC filing metadata
- accession: 0001683168-26-005616
- form_type: 8-K
- ticker: ACTU
- cik: 0001652935
- company_name: ACTUATE THERAPEUTICS, INC.
- filed_at: 2026-07-17T20:30:34+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1652935/000168316826005616/0001683168-26-005616-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1652935/000168316826005616/actuate_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-005616
- JSON: https://secwatch.observer/filing/0001683168-26-005616.json
- Plain text: https://secwatch.observer/filing/0001683168-26-005616.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.